Advertisement

Structure and Biology of Self Lipid Antigens

  • G. De Libero
  • L. Mori
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 314)

Keywords

Acyl Chain Late Endosome Microsomal Triglyceride Transfer Protein Primary Progressive Multiple Sclerosis Lipid Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Acarin N, Rio J, Fernandez AL, Tintore M, Duran I, Galan I, Montalban X (1996) Different antiganglioside antibody patterns between relapsing-remitting and progressive multiple sclerosis. Acta Neurol Scand 93:99–103PubMedCrossRefGoogle Scholar
  2. Agea E, Russano A, Bistoni O, Mannucci R, Nicoletti I, Corazzi L, Postle AD, De Libero G, Porcelli SA, Spinozzi F (2005) Human CD1-restricted T cell recognition of lipids from pollens. J Exp Med 202:295–308PubMedCrossRefGoogle Scholar
  3. Allende ML, Li J, Darling DS, Worth CA, Young WW Jr (2000) Evidence supporting a late Golgi location for lactosylceramide to ganglioside GM3 conversion. Glycobiology 10:1025–1032PubMedCrossRefGoogle Scholar
  4. Arnon R, Crisp E, Kelley R, Ellison GW, Myers LW, Tourtellotte WW (1980) Anti-ganglioside antibodies in multiple sclerosis. J Neurol Sci 46:179–186PubMedCrossRefGoogle Scholar
  5. Bendelac A, Rivera MN, Park SH, Roark JH (1997) Mouse CD1-specific NK1. T cells: development, specificity, and function. Annu Rev Immunol 15:535–562PubMedCrossRefGoogle Scholar
  6. Borowski C, Bendelac A (2005) Signaling for NKT cell development: the SAP-FynT connection. J Exp Med 201:833–836PubMedCrossRefGoogle Scholar
  7. Brozovic S, Nagaishi T, Yoshida M, Betz S, Salas A, Chen D, Kaser A, Glickman J, Kuo T, Little A, Morrison J, Corazza N, Kim JY, Colgan SP, Young SG, Exley M, Blumberg RS (2004) CD1d function is regulated by microsomal triglyceride transfer protein. Nat Med 10:535–539PubMedCrossRefGoogle Scholar
  8. De la Salle H, Mariotti S, Angenieux C, Gilleron M, Garcia-Alles LF, Malm D, Berg T, Paoletti S, Maitre B, Mourey L, Salamero J, Cazenave JP, Hanau D, Mori L, Puzo G, De Libero G (2005) Assistance of microbial glycolipid antigen processing by CD1e. Science 310:1321–1324PubMedCrossRefGoogle Scholar
  9. De Libero G, Moran AP, Gober H-J, Rossy E, Shamshiev A, Chelnokova O, Mazorra Z, Vendetti S, Sacchi A, Prendergast MM, Sansano S, Tonevitsky A, Landmann R, Mori L (2005) Bacterial infections promote T cell recognition of self-glycolipids. Immunity 22:763–772PubMedCrossRefGoogle Scholar
  10. Dougan SK, Salas A, Rava P, Agyemang A, Kaser A, Morrison J, Khurana A, Kronenberg M, Johnson C, Exley M, Hussain MM, Blumberg RS (2005) Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J Exp Med 202:529–539PubMedCrossRefGoogle Scholar
  11. Dumonceaux T, Carlsen SA (2001) Isogloboside biosynthesis in metastatic R3230AC cells results from a decreased GM3 synthase activity. Arch Biochem Biophys 389:187–194PubMedCrossRefGoogle Scholar
  12. Endo T, Scott DD, Stewart SS, Kundu SK, Marcus DM (1984) Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol 132:1793–1797PubMedGoogle Scholar
  13. Ernst WA, Maher J, Cho S, Niazi KR, Chatterjee D, Moody DB, Besra GS, Watanabe Y, Jensen PE, Porcelli SA, Kronenberg M, Modlin RL (1998) Molecular interaction of CD1b with lipoglycan antigens. Immunity 8:331–340PubMedCrossRefGoogle Scholar
  14. Futerman AH, Stieger B, Hubbard AL, Pagano RE (1990) Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus. J Biol Chem 265:8650–8657PubMedGoogle Scholar
  15. Garcia-Alles LF, Versluis K, Maveyraud L, Vallina AT, Sansano S, Bello NF, Gober HJ, Guillet V, de la Salle H, Puzo G, Mori L, Heck AJ, De Libero G, Mourey L (2006) Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b. EMBO J 25:3684–3692PubMedCrossRefGoogle Scholar
  16. Giabbai B, Sidobre S, Crispin MD, Sanchez-Ruiz Y, Bachi A, Kronenberg M, Wilson IA, Degano M (2005) Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: amolecular basis for NKT cell activation. J Immunol 175:977–984PubMedGoogle Scholar
  17. Giraudo CG, Rosales Fritz VM, Maccioni HJ (1999) GA2/GM2/GD2 synthase localizes to the trans-Golgi network of CHO-K1 cells. Biochem J 342:633–640PubMedCrossRefGoogle Scholar
  18. Giraudo CG, Daniotti JL, Maccioni HJ (2001) Physical and functional association of glycolipid N-acetyl-galactosaminyl and galactosyl transferases in the Golgi apparatus. Proc Natl Acad Sci U S A 98:1625–1630PubMedCrossRefGoogle Scholar
  19. Godfrey DI, Kronenberg M (2004) Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 114:1379–1388PubMedCrossRefGoogle Scholar
  20. Gumperz JE, Roy C, Makowska A, Lum D, Sugita M, Podrebarac T, Koezuka Y, Porcelli SA, Cardell S, Brenner MB, Behar SM (2000) Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12:211–221PubMedCrossRefGoogle Scholar
  21. Hakomori S (1981) Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu Rev Biochem 50:733–764PubMedCrossRefGoogle Scholar
  22. Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M (2003) Molecular machinery for non-vesicular trafficking of ceramide. Nature 426:803–809PubMedCrossRefGoogle Scholar
  23. Holthuis JC, Levine TP (2005) Lipid traffic: floppy drives and a superhighway. Nat Rev Mol Cell Biol 6:209–220PubMedCrossRefGoogle Scholar
  24. Holthuis JC, van Meer G, Huitema K (2003) Lipid microdomains, lipid translocation and the organization of intracellular membrane transport. Mol Membr Biol 20:231–241PubMedCrossRefGoogle Scholar
  25. Jahng A, Maricic I, Aguilera C, Cardell S, Halder RC, Kumar V (2004) Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med 199:947–957PubMedCrossRefGoogle Scholar
  26. Jayawardena-Wolf J, Benlagha K, Chiu YH, Mehr R, Bendelac A (2001) CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 15:897–908PubMedCrossRefGoogle Scholar
  27. Jeckel D, Karrenbauer A, Burger KN, van Meer G, Wieland F (1992) Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. J Cell Biol 117:259–267PubMedCrossRefGoogle Scholar
  28. Kang SJ, Cresswell P (2002) Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules. EMBO J 21:1650–1660PubMedCrossRefGoogle Scholar
  29. Kang SJ, Cresswell P (2004) Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat Immunol 5:175–181PubMedCrossRefGoogle Scholar
  30. Kanter JL, Narayana S, Ho PP, Catz I, Warren KG, Sobel RA, Steinman L, Robinson WH (2006) Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 12:138–143PubMedCrossRefGoogle Scholar
  31. Kawahara K, Kuraishi H, Zahringer U (1999) Chemical structure and function of glycosphingolipids of Sphingomonas spp and their distribution among members of the alpha-4 subclass of Proteobacteria. J Ind Microbiol Biotechnol 23:408–413PubMedCrossRefGoogle Scholar
  32. Kawashima T, Norose Y, Watanabe Y, Enomoto Y, Narazaki H, Watari E, Tanaka S, Takahashi H, Yano I, Brenner MB, Sugita M (2003) Cutting edge: major CD8. T cell response to live bacillus Calmette-Guerin is mediated by CD1 molecules. J Immunol 170:5345–5348PubMedGoogle Scholar
  33. Kinjo Y, Wu D, Kim G, Xing G-W, Poles MA, Ho DH, Tsuji M, Kawahara K, Wong C-H, Kronenberg M (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434:520–525PubMedCrossRefGoogle Scholar
  34. Kronenberg M, Gapin L (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol 2:557–568PubMedGoogle Scholar
  35. Kusunoki S, Yu RK, Kim JH (1988) Induction of experimental autoimmune encephalomyelitis in guinea pigs using myelin basic protein and myelin glycolipids. J Neuroimmunol 18:303–314PubMedCrossRefGoogle Scholar
  36. Lannert H, Gorgas K, Meissner I, Wieland FT, Jeckel D (1998) Functional organization of the Golgi apparatus in glycosphingolipid biosynthesis. Lactosylceramide and subsequent glycosphingolipids are formed in the lumen of the late Golgi. J Biol Chem 273:2939–2946PubMedCrossRefGoogle Scholar
  37. MacDonald HR, Schumann J (2005) The need for natural killer T cells. Nat Med 11:256–257PubMedCrossRefGoogle Scholar
  38. Mandon EC, Ehses I, Rother J, van Echten G, Sandhoff K (1992) Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver. J Biol Chem 267:11144–11148PubMedGoogle Scholar
  39. Manolova V, Kistowska M, Paoletti S, Baltariu GM, Bausinger H, Hanau D, Mori L, De Libero G (2006) Functional CD1a is stabilized by exogenous lipids. Eur J Immunol 36:1083–1092PubMedCrossRefGoogle Scholar
  40. Mattner J, DeBord KL, Ismail N, Goff RD, Cantu C 3rd, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A (2005) Both exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525–529PubMedCrossRefGoogle Scholar
  41. Melian A, Watts GF, Shamshiev A, De Libero G, Clatworthy A, Vincent M, Brenner MB, Behar S, Niazi K, Modlin RL, Almo S, Ostrov D, Nathenson SG, Porcelli SA (2000) Molecular recognition of human CD1b antigen complexes: evidence for a common pattern of interaction with alpha beta TCRs. J Immunol 165:4494–4504PubMedGoogle Scholar
  42. Miyamoto K, Miyake S, Yamamura T (2001) A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413:531–534PubMedCrossRefGoogle Scholar
  43. Moody DB, Porcelli SA (2003) Intracellular pathways of CD1 antigen presentation. Nat Rev Immunol 3:11–22PubMedCrossRefGoogle Scholar
  44. Moody DB, Briken V, Cheng TY, Roura-Mir C, Guy MR, Geho DH, Tykocinski ML, Besra GS, Porcelli SA (2002) Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat Immunol 3:435–442PubMedGoogle Scholar
  45. Moore GR, Traugott U, Farooq M, Norton WT, Raine CS (1984) Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids. Lab Invest 51:416–424PubMedGoogle Scholar
  46. Moran AP, Prendergast MM (2001) Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity. J Autoimmun 16:241–256PubMedCrossRefGoogle Scholar
  47. Mullin BR, Patrick DH, Poore CM, Rupp BH, Smith MT (1986) Prevention of experimental allergic encephalomyelitis by ganglioside GM4. A follow-up study. J Neurol Sci 73:55–60PubMedCrossRefGoogle Scholar
  48. Ndonye RM, Izmirian DP, Dunn MF, Yu KO, Porcelli SA, Khurana A, Kronenberg M, Richardson SK, Howell AR (2005) Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH. J Org Chem 70:10260–10270PubMedCrossRefGoogle Scholar
  49. Oki S, Chiba A, Yamamura T, Miyake S (2004) The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J Clin Invest 113:1631–1640PubMedCrossRefGoogle Scholar
  50. Oki S, Tomi C, Yamamura T, Miyake S (2005) Preferential T(h)2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo. Int Immunol 17:1619–1629PubMedCrossRefGoogle Scholar
  51. Pender MP, Csurhes PA, Wolfe NP, Hooper KD, Good MF, McCombe PA, Greer JM (2003) Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis. J Clin Neurosci 10:63–66PubMedCrossRefGoogle Scholar
  52. Pomorski T, Hrafnsdottir S, Devaux PF, van Meer G (2001) Lipid distribution and transport across cellular membranes. Semin Cell Dev Biol 12:139–148PubMedCrossRefGoogle Scholar
  53. Prigozy TI, Naidenko O, Qasba P, Elewaut D, Brossay L, Khurana A, Natori T, Koezuka Y, Kulkarni A, Kronenberg M (2001) Glycolipid antigen processing for presentation by CD1d molecules. Science 291:664–667PubMedCrossRefGoogle Scholar
  54. Prinetti A, Basso L, Appierto V, Villani MG, Valsecchi M, Loberto N, Prioni S, Chigorno V, Cavadini E, Formelli F, Sonnino S (2003) Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells. J Biol Chem 278:5574–5583PubMedCrossRefGoogle Scholar
  55. Rauch J, Gumperz J, Robinson C, Skold M, Roy C, Young DC, Lafleur M, Moody DB, Brenner MB, Costello CE, Behar SM (2003) Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J Biol Chem 278:47508–47515PubMedCrossRefGoogle Scholar
  56. Ruan S, Lloyd KO (1992) Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns. Cancer Res 52:5725–5731PubMedGoogle Scholar
  57. Sadatipour BT, Greer JM, Pender MP (1998) Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis. Ann Neurol 44:980–983PubMedCrossRefGoogle Scholar
  58. Schwerer B, Kitz K, Lassmann H, Bernheimer H (1984) Serum antibodies against glycosphingolipids in chronic relapsing experimental allergic encephalomyelitis. Demonstration by ELISA and relation to serum in vivo demyelinating activity. J Neuroimmunol 7:107–119PubMedCrossRefGoogle Scholar
  59. Shamshiev A, Donda A, Carena I, Mori L, Kappos L, De Libero G (1999) Self glycolipids as T-cell autoantigens. Eur J Immunol 29:1667–1675PubMedCrossRefGoogle Scholar
  60. Shamshiev A, Donda A, Prigozy TI, Mori L, Chigorno V, Benedict CA, Kappos L, Sonnino S, Kronenberg M, De Libero G (2000) The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity 13:255–264PubMedCrossRefGoogle Scholar
  61. Shamshiev A, Gober HJ, Donda A, Mazorra Z, Mori L, De Libero G (2002) Presentation of the same glycolipid by different CD1 molecules. J Exp Med 195:1013–1021PubMedCrossRefGoogle Scholar
  62. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC (1994) Crystal structure of the human class IIMHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215–221PubMedCrossRefGoogle Scholar
  63. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H (2003) The regulatory role of Valpha14. NKT cells in innate and acquired immune response. Annu Rev Immunol 21:483–513PubMedCrossRefGoogle Scholar
  64. Ulrichs T, Moody DB, Grant E, Kaufmann SH, Porcelli SA (2003) T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection. Infect Immun 71:3076–3087PubMedCrossRefGoogle Scholar
  65. Van Kaer L (2005) Alpha-galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat Rev Immunol 5:31–42PubMedCrossRefGoogle Scholar
  66. Van Meer G, Holthuis JC (2000) Sphingolipid transport in eukaryotic cells. Biochim Biophys Acta 1486:145–170PubMedGoogle Scholar
  67. Warnock DE, Lutz MS, Blackburn WA, Young WW Jr, Baenziger JU (1994) Transport of newly synthesized glucosylceramide to the plasma membrane by a non-Golgi pathway. Proc Natl Acad Sci U S A 91:2708–2712PubMedCrossRefGoogle Scholar
  68. Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591–2625PubMedCrossRefGoogle Scholar
  69. Winau F, Schwierzeck V, Hurwitz R, Remmel N, Sieling PA, Modlin RL, Porcelli SA, Brinkmann V, Sugita M, Sandhoff K, Kaufmann SH, Schaible UE (2004) Saposin C is required for lipid presentation by human CD1b. Nat Immunol 5:169–174PubMedCrossRefGoogle Scholar
  70. Wu DY, Segal NH, Sidobre S, Kronenberg M, Chapman PB (2003) Cross-presentation of disialoganglioside GD3 to natural killer T cells. J Exp Med 198:173–181PubMedCrossRefGoogle Scholar
  71. Yamashiro S, Ruan S, Furukawa K, Tai T, Lloyd KO, Shiku H (1993) Genetic and enzymatic basis for the differential expression of GM2 and GD2 gangliosides in human cancer cell lines. Cancer Res 53:5395–5400PubMedGoogle Scholar
  72. Zajonc DM, Elsliger MA, Teyton L, Wilson IA (2003) Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A. Nat Immunol 4:808–815PubMedCrossRefGoogle Scholar
  73. Zajonc DM, Cantu C 3rd, Mattner J, Zhou D, Savage PB, Bendelac A, Wilson IA, Teyton L (2005) Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat Immunol 6:810–818PubMedCrossRefGoogle Scholar
  74. Zhou D, Cantu C, 3rd Sagiv Y, Schrantz N, Kulkarni AB, Qi X, Mahuran DJ, Morales CR, Grabowski GA, Benlagha K, Savage P, Bendelac A, Teyton L (2004a) Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303:523–527PubMedCrossRefGoogle Scholar
  75. Zhou D, Mattner J, Cantu C 3rd, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu YP, Yamashita T, Teneberg S, Wang D, Proia RL, Levery SB, Savage PB, Teyton L, Bendelac A (2004b) Lysosomal glycosphingolipid recognition by NKT cells. Science 306:1786–1789PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2007

Authors and Affiliations

  • G. De Libero
    • 1
  • L. Mori
    • 1
  1. 1.Department of ResearchUniversity HospitalBaselSwitzerland

Personalised recommendations